139 related articles for article (PubMed ID: 15288572)
1. Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptors.
Kelley BG; Thayer SA
Eur J Pharmacol; 2004 Aug; 496(1-3):33-9. PubMed ID: 15288572
[TBL] [Abstract][Full Text] [Related]
2. AM404 decreases Fos-immunoreactivity in the spinal cord in a model of inflammatory pain.
Borsani E; Labanca M; Bianchi R; Rodella LF
Brain Res; 2007 Jun; 1152():87-94. PubMed ID: 17459353
[TBL] [Abstract][Full Text] [Related]
3. The anandamide transport inhibitor AM404 reduces ethanol self-administration.
Cippitelli A; Bilbao A; Gorriti MA; Navarro M; Massi M; Piomelli D; Ciccocioppo R; Rodríguez de Fonseca F
Eur J Neurosci; 2007 Jul; 26(2):476-86. PubMed ID: 17650118
[TBL] [Abstract][Full Text] [Related]
4. Divergent effects of anandamide transporter inhibitors with different target selectivity on social play behavior in adolescent rats.
Trezza V; Vanderschuren LJ
J Pharmacol Exp Ther; 2009 Jan; 328(1):343-50. PubMed ID: 18948500
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology.
Giuffrida A; Beltramo M; Piomelli D
J Pharmacol Exp Ther; 2001 Jul; 298(1):7-14. PubMed ID: 11408519
[TBL] [Abstract][Full Text] [Related]
6. AM404, an inhibitor of anandamide reuptake decreases Fos-immunoreactivity in the spinal cord of neuropathic rats after non-noxious stimulation.
Rodella LF; Borsani E; Rezzani R; Ricci F; Buffoli B; Bianchi R
Eur J Pharmacol; 2005 Jan; 508(1-3):139-46. PubMed ID: 15680264
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid activation of recombinant and endogenous vanilloid receptors.
Ralevic V; Kendall DA; Jerman JC; Middlemiss DN; Smart D
Eur J Pharmacol; 2001 Jul; 424(3):211-9. PubMed ID: 11672565
[TBL] [Abstract][Full Text] [Related]
8. AM404 and VDM 11 non-specifically inhibit C6 glioma cell proliferation at concentrations used to block the cellular accumulation of the endocannabinoid anandamide.
Jonsson KO; Andersson A; Jacobsson SO; Vandevoorde S; Lambert DM; Fowler CJ
Arch Toxicol; 2003 Apr; 77(4):201-7. PubMed ID: 12698235
[TBL] [Abstract][Full Text] [Related]
9. The anandamide transport inhibitor AM404 activates vanilloid receptors.
Zygmunt PM; Chuang H; Movahed P; Julius D; Högestätt ED
Eur J Pharmacol; 2000 May; 396(1):39-42. PubMed ID: 10822052
[TBL] [Abstract][Full Text] [Related]
10. Transient receptor potential vanilloid subtype 1 mediates cell death of mesencephalic dopaminergic neurons in vivo and in vitro.
Kim SR; Lee DY; Chung ES; Oh UT; Kim SU; Jin BK
J Neurosci; 2005 Jan; 25(3):662-71. PubMed ID: 15659603
[TBL] [Abstract][Full Text] [Related]
11. Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons.
Guo J; Ikeda SR
Mol Pharmacol; 2004 Mar; 65(3):665-74. PubMed ID: 14978245
[TBL] [Abstract][Full Text] [Related]
12. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
[TBL] [Abstract][Full Text] [Related]
13. Acyl-based anandamide uptake inhibitors cause rapid toxicity to C6 glioma cells at pharmacologically relevant concentrations.
De Lago E; Gustafsson SB; Fernández-Ruiz J; Nilsson J; Jacobsson SO; Fowler CJ
J Neurochem; 2006 Oct; 99(2):677-88. PubMed ID: 16899063
[TBL] [Abstract][Full Text] [Related]
14. Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404.
Giuffrida A; Rodriguez de Fonseca F; Nava F; Loubet-Lescoulié P; Piomelli D
Eur J Pharmacol; 2000 Nov; 408(2):161-8. PubMed ID: 11080522
[TBL] [Abstract][Full Text] [Related]
15. Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor.
Beltramo M; de Fonseca FR; Navarro M; Calignano A; Gorriti MA; Grammatikopoulos G; Sadile AG; Giuffrida A; Piomelli D
J Neurosci; 2000 May; 20(9):3401-7. PubMed ID: 10777802
[TBL] [Abstract][Full Text] [Related]
16. The effects of anandamide transport inhibitor AM404 on voltage-dependent calcium channels.
Alptekin A; Galadari S; Shuba Y; Petroianu G; Oz M
Eur J Pharmacol; 2010 May; 634(1-3):10-5. PubMed ID: 20171208
[TBL] [Abstract][Full Text] [Related]
17. A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes.
Rockwell CE; Kaminski NE
J Pharmacol Exp Ther; 2004 Nov; 311(2):683-90. PubMed ID: 15284281
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of anandamide hypotension by the transport inhibitor, AM404.
Calignano A; La Rana G; Beltramo M; Makriyannis A; Piomelli D
Eur J Pharmacol; 1997 Oct; 337(1):R1-2. PubMed ID: 9389389
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of receptor types mediating the dilator action of anandamide on blood vessels of the rat knee joint.
Lam FF; Luk PW; Ng ES
Life Sci; 2007 Mar; 80(16):1495-502. PubMed ID: 17275857
[TBL] [Abstract][Full Text] [Related]
20. The endogenous cannabinoid anandamide inhibits alpha7 nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes.
Oz M; Ravindran A; Diaz-Ruiz O; Zhang L; Morales M
J Pharmacol Exp Ther; 2003 Sep; 306(3):1003-10. PubMed ID: 12766252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]